Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, 100850, China.
Front Med. 2021 Apr;15(2):178-207. doi: 10.1007/s11684-020-0793-6. Epub 2020 Oct 19.
Breast cancer is one of the most common malignancies that seriously threaten women's health. In the process of the malignant transformation of breast cancer, metabolic reprogramming and immune evasion represent the two main fascinating characteristics of cancer and facilitate cancer cell proliferation. Breast cancer cells generate energy through increased glucose metabolism. Lipid metabolism contributes to biological signal pathways and forms cell membranes except energy generation. Amino acids act as basic protein units and metabolic regulators in supporting cell growth. For tumor-associated immunity, poor immunogenicity and heightened immunosuppression cause breast cancer cells to evade the host's immune system. For the past few years, the complex mechanisms of metabolic reprogramming and immune evasion are deeply investigated, and the genes involved in these processes are used as clinical therapeutic targets for breast cancer. Here, we review the recent findings related to abnormal metabolism and immune characteristics, regulatory mechanisms, their links, and relevant therapeutic strategies.
乳腺癌是严重威胁女性健康的最常见恶性肿瘤之一。在乳腺癌的恶性转化过程中,代谢重编程和免疫逃逸代表了癌症的两个主要迷人特征,促进了癌细胞的增殖。乳腺癌细胞通过增加葡萄糖代谢产生能量。脂质代谢除了产生能量外,还有助于生物信号通路的形成和细胞膜的形成。氨基酸作为支持细胞生长的基本蛋白质单位和代谢调节剂。对于肿瘤相关免疫,较差的免疫原性和增强的免疫抑制使乳腺癌细胞逃避宿主的免疫系统。在过去的几年中,代谢重编程和免疫逃逸的复杂机制得到了深入研究,涉及这些过程的基因被用作乳腺癌的临床治疗靶点。在这里,我们回顾了与异常代谢和免疫特征、调节机制、它们的联系以及相关治疗策略相关的最新发现。